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ABSTRACT
Occludin is a transmembrane tight junction (TJ)
protein that plays an important role in TJ assembly
and regulation of the epithelial barrier function, but
the mechanisms underlying its post-transcriptional
regulation are unknown. The RNA-binding protein
HuR modulates the stability and translation of many
target mRNAs. Here, we investigated the role of HuR
in the regulation of occludin expression and there-
fore in the intestinal epithelial barrier function. HuR
bound the 30-untranslated region of the occludin
mRNA and enhanced occludin translation. HuR as-
sociation with the occludin mRNA depended on
Chk2-dependent HuR phosphorylation. Reduced
HuR phosphorylation by Chk2 silencing or by reduc-
tion of Chk2 through polyamine depletion decreased
HuR-binding to the occludin mRNA and repressed
occludin translation, whereas Chk2 overexpression
enhanced (HuR/occludin mRNA) association
and stimulated occludin expression. In mice
exposed to septic stress induced by cecal ligation
and puncture, Chk2 levels in the intestinal mu-
cosa decreased, associated with an inhibition
of occludin expression and gut barrier dysfunction.
These results indicate that HuR regulates occludin
mRNA translation through Chk2-dependent HuR
phosphorylation and that this influence is crucial
for maintenance of the epithelial barrier integrity in
the intestinal tract.
INTRODUCTION
Epithelial cells line the intestinal mucosa and establish an
important barrier that protects the subepithelial tissue
against a wide array of noxious substances in the lumen
(1–3). Disruption of this barrier occurs commonly in vari-
ous pathological conditions, leading to the translocation
of luminal toxic substances and bacteria to the blood-
stream (3). The integrity and normal function of the epi-
thelial barrier depend on specialized structures composing
different intercellular junctions including tight junctions
(TJs) and adherens junctions (AJs) (4,5). The TJs
located at the apical region of the epithelial lateral mem-
brane provide the barrier that is selectively permeable to
certain hydrophilic molecules, ions and nutrients (2,6),
whereas AJs mediate strong cell-to-cell adhesions between
adjacent epithelial cells and regulate TJ assembly and
function (7,8). TJs primarily consist of transmembrane
proteins such as occludin, tricellulin and one or more mem-
bers of the claudin family; these proteins also associate
with a cytosolic plaque of proteins such as zonula
occludens (ZO)-1 and ZO-2 that link tightly to the cortical
cytoskeleton (1,2,9). Despite considerable efforts from
many laboratories, the precise mechanisms underlying
TJ assembly and the coordination of signals and barrier
activity in response to stress are still poorly understood.
To date, four classes of TJ transmembrane proteins and
>30 TJ membrane-associated proteins have been identi-
ﬁed in mammalian epithelial and endothelial cells (2,3);
the major transmembrane and cytosolic TJ proteins ex-
pressed in the intestinal epithelium include occludin,
claudins, ZO-1 and ZO-2 (1,6). Occludin is an integral
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junction complexes and is required for normal TJ physi-
ology (10,11). Occludin has a tetraspanning membrane
topology with two extracellular loops and three cytoplas-
mic domains, among which the extracellular loops are
important for occludin localization (12,13). Occludin is
important for normal function of the gut barrier (12,14)
and is also involved in the regulation of other cellular
functions such as directional migration of epithelial cells
(15). Ectopic expression of wild-type occludin increases the
number of TJ strands and promotes the epithelial barrier
function (16), while inhibition of occludin function by
overexpressing the dominant negative occludin mutant dis-
rupts TJ structures and results in dysfunction of the epi-
thelial barrier (17). The levels of TJs including occludin
change dynamically and are tightly regulated by numer-
ous factors (18–20), but the exact mechanism underlying
the regulation of TJ expression remains to be fully
elucidated.
Although gene expression is critically regulated at the
transcriptional level, the essential contribution of post-
transcriptional events, particularly altered mRNA turnover
and translation, in the control of gene expression programs
in the intestinal mucosa is increasingly recognized (21–24).
The post-transcriptional fate of a given mRNA is primar-
ily controlled by the interaction of speciﬁc mRNA se-
quences (cis-elements) with speciﬁc trans-acting factors
such as RNA-binding proteins (RBPs) (25–28) and
microRNAs (29,30). The most common cis-elements re-
sponsible for rapid regulation of mRNA decay and trans-
lation in mammalian cells are U- and AU-rich elements
located in the 30-untranslated regions (30-UTRs) of many
mRNAs (31). Ribonucleoprotein (RNP) associations ei-
ther increase or decrease mRNA stability and/or transla-
tion depending on the particular mRNA sequence, the
cellular growth conditions and the stimulus type (25,32,33).
Among the RBPs that regulate speciﬁc subsets of mRNAs
are several that modulate mRNA turnover (HuR, NF90,
AUF1, BRF1, TTP, KSRP) and several that modulate
translation (HuR, TIAR, NF90, TIA-1), collectively
known as translation and turnover-regulatory (TTR)-
RBPs (34,35). In cells responding to stressful environmen-
tal conditions, TTR-RBPs bind to the speciﬁc sequences in
the 30-UTRs of collections of target mRNAs and govern
their turnover and translation rates (36–39).
HuR is one of the best-studied RBPs in the intestinal
mucosa (20–23,40). It is characterized by the presence of
two N-terminal RNA recognition motifs (RRMs) with
high afﬁnity for speciﬁc U- and AU-rich elements, and a
C-terminal RRM that recognizes the poly(A) tail (41). The
function of HuR is tightly regulated by altering its
subcellular distribution, by its phosphorylation status, and
by the presence of other factors, such as microRNAs,
interacting with the target mRNA (29,42,43). The check-
point kinase Chk2 was recently shown to phosphorylate
HuR and thereby modulate the afﬁnity of HuR for its
target transcripts after exposure to oxidative stress and
polyamine depletion (22,42). In addition, HuR phosphor-
ylation by protein kinase Ca elevates its cytoplasmic abun-
dance (38), whereas cyclin-dependent kinase-1-mediated
HuR phosphorylation prevents the cytoplasmic
accumulation of HuR (44). In this study, we sought to
directly investigate the role of HuR in the regulation of
occludin expression and therefore in the intestinal epithe-
lial barrier function in vitro as well as in vivo. The data
presented here indicate that HuR directly interacts with
and enhances occludin mRNA translation through
Chk2-dependent HuR phosphorylation, thus promoting
the epithelial barrier function. Conversely, reduced HuR
association with occludin mRNA following inhibition of
Chk2 or exposure to septic stress inhibits occludin expres-
sion and results in barrier dysfunction.
MATERIALS AND METHODS
Chemicals and supplies
Tissue culture medium and dialyzed fetal bovine serum
were from Invitrogen (Carlsbad, CA, USA) and biochem-
icals were from Sigma (St Louis, MO, USA). The antibodies
recognizing HuR, occludin, Chk2 and b-actin were ob-
tained from Santa Cruz Biotechnology (Santa Cruz, CA)
and BD Bioscience, and the antibody against all phospho-
rylated proteins (Cat No. 61-8300) was from Zymed
Laboratories (South San Francisco, CA, USA). The sec-
ondary antibody conjugated to horseradish peroxidase
was purchased from Sigma. The 12-mm Transwell ﬁl-
ters were obtained from Costar Corp; L-[
35S]methionine,
L-[
35S]cysteine, and [
14C]mannitol were obtained from NEN
Radiopharmaceutical. DFMO (a-diﬂuoromethylorni-
thine) was from GENZYME (Cambridge, MA, USA).
Cell culture and animals
Stable Cdx2-transfected intestinal epithelial cells (IEC-
Cdx2L1) were developed from IEC-6 cells (45), derived
from normal rat intestinal crypt cells (46), and maintained
as described previously (20). Before experiments, IEC-
Cdx2L1 cells were grown in DMEM containing 4mM
IPTG for 16 days to induce cell differentiation as desc-
ribed earlier (20,47). The Caco-2 cells (a human colon
carcinoma cell line) were cultured similarly to the IEC-
Cdx2L1 cells.
A/J mice (male, 6–9 weeks old) were purchased from
The Jackson Laboratory and housed in speciﬁc pathogen-
free animal facility at the Baltimore VA Medical Center.
All animal experiments were conducted in accordance with
NIH guidelines and were approved by the Institutional
Animal Care and Use Committee of University Maryland
School of Medicine and Baltimore VA hospital.
Plasmid construction
The Chk2 expression vector was described previously (42).
The vectors expressing wild-type HuR-TAP fusion pro-
teins or point-mutated HuR-TAP fusion proteins were
generated by site-directed mutagenesis as described (22,42).
The chimeric ﬁreﬂy luciferase reporter construct contain-
ing the occludin 30-UTR (http://www.ncbi.nlm.nih.gov/
gene/83497) was generated as described (19,21). The
full-length 30-UTR of rat occludin mRNA was ampliﬁed
and subcloned into the pGL3-Luc plasmid (Promega) at
the Xba1 site to generate the chimeric pGL3-Luc-
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The sequence and orientation of the luciferase reporter
were veriﬁed by DNA sequencing and enzyme digestion.
Transient transfections were performed using the
Lipofectamine Reagent following recommendations by the
manufacturer (Invitrogen). The luciferase reporter con-
structs were transfected into cells along with phRL-null,
a Renilla luciferase control reporter vector from Promega,
to monitor transfection efﬁciencies as described (22).
Luciferase activity was measured using the Dual Luciferase
Assay System. To measure translational changes (transla-
tional efﬁciency), the Fireﬂy to Renilla luciferase ratio
was further normalized with RNA levels.
RNA interference
HuR and Chk2 were silenced by transfection with speciﬁc
small interfering RNA (siRNA) as described (22,27). The
siRNAs speciﬁcally targeting HuR mRNA (siHuR) or Chk2
mRNA (siChk2) and control-siRNA (C-siRNA) were pur-
chased from Dharmacon (Supplementary Table S1). For
each 60-mm cell culture dish, 15ml of the 20mM stock du-
plex siHuR, siChk2 or C-siRNA was used. Forty-eight
hours after transfection using LipofectAMINE, cells were
harvested for analysis.
Western blot analysis
Whole-cell lysates were prepared using 2% SDS, sonicated
and centrifuged at 4 C for 15min. The supernatants were
boiled for 5min and size-fractionated by SDS–PAGE.
After transferring proteins onto nitrocellulose ﬁlters, the
blots were incubated with primary antibodies recognizing
occludin, HuR and Chk2 proteins; following incubations
with secondary antibodies, immunocomplexes were de-
veloped by using chemiluminescence.
RT–PCR and real-time quantitative PCR analysis
Total RNA was isolated by using RNeasy mini kit and
used in reverse transcription and PCR ampliﬁcation reac-
tions as described (43). PCR primers for detecting occludin
mRNA were TTGGGACAGAGGCTATGG (sense) and
ACCCACTCTTCAACATTGGG (antisense). The levels
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
PCR product were assessed to monitor the evenness in
RNA input in RT–PCR samples. Real-time quantitative
PCR (qPCR) analysis was performed using 7500-Fast
Real-Time PCR Systems with speciﬁc primers, probes and
software (Applied Biosystems, Foster City, CA, USA).
Measurement of newly translated protein and polysome
analysis
New synthesis of occludin protein was measured by
L-[
35S]methionine and L-[
35S]cysteine incorporation assays
as described (22,44). Cells were incubated with 1mCi
(1Ci=37 GBq) L-[
35S]methionine and L-[
35S]cysteine
per 60-mm plate for 30min, where upon cells were lysed
using RIPA buffer. Immunoprecipitations were carried out
for 1h at 4 C using either an antibody recognizing
occludin or IgG1 (BD Pharmingen). Following extensive
washes in TNN buffer [50 mM Tris–HCl (pH 7.5),
250mM NaCl, 5mM EDTA, 0.5% NP-40], the immuno-
precipitated material was resolved by 10% SDS–PAGE,
transferred onto PVDF ﬁlters, and visualized with a
PhosphorImager (Molecular Dynamics).
Polysome analysis was performed as described (48).
Brieﬂy, cells were incubated for 15min in 0.1mg/ml
cycloheximide and then lifted by scraping in 1ml PEB lysis
buffer (0.3M NaCl, 15mM MgCl 2,1 5 m MT r i s – H C l ,
pH 7.6, 1% Triton X-100, 1mg/ml heparin, and 0.1mg/
ml cycloheximide) and lysed on ice for 10min. Nuclei were
pelleted (10000g, 10min) and the resulting supernatant
was fractionated through a 10–50% linear sucrose
gradient to fractionate cytoplasmic components according
to their molecular weights. The eluted fractions were
prepared with a fraction collector (Brandel) and their
quality was monitored at 254nm using a UV-6 detector
(ISCO). After the RNA in each fraction was extracted with
8M guanidine–HCl, the levels of each individual mRNA
were quantiﬁed by qPCR analysis in each of the fractions,
and their abundance represented as a percent of the total
mRNA in the gradient.
Biotin pull-down assays
The synthesis of biotinylated transcripts and analysis of
RBPs bound to biotinylated RNA were done as described
(23). Complementary DNA from IEC-Cdx2L1 cells was
used as a template for PCR ampliﬁcation of the coding
region (CR) and 30-UTR of occludin. The 50 primers con-
tained the T7 RNA polymerase promoter sequence (T7)C
CAAGCTTCTAATACGACTCAC TATAGGGAGA.
To prepare the occludin CR template (spanning position
149–1721), oligonucleotides (T7)CCATGTCTGTGAGG
CCTTTT and CTCTGGGGAGAACTGCAGAC were
used. To prepare the occludin 30-UTR template (spanning
position 1720–4148), oligonucleotides (T7)CAAGAGGA
TGGTGGGAGACT and ATATAAAGCACATACAAC
AA AACGTCA were used. All sequences of oligonucleo-
tides for preparation of various short RNA probes for
mapping the occludin 30-UTR were described in
Supplementary Table S2. PCR-ampliﬁed products were
used as templates to transcribe biotinylated RNAs by
using T7 RNA polymerase in the presence of biotin-
cytidine 50-triphosphate as described (49). Biotinylated
transcripts (6mg) were incubated with 120mg of cytoplas-
mic lysates for 30min at room temperature. Complexes
were isolated with paramagnetic streptavidin-conjugated
Dynabeads (Dynal, Oslo, Norway) and analyzed by
western blot analysis.
RNP IP assays
To assess the association of endogenous HuR with en-
dogenous occludin mRNA, immunoprecipitation (IP) of
ribonucleoprotein (RNP) complexes were performed as
described (50). Twenty million cells were collected per
sample, and lysates were used for IP for 4h at room tem-
perature in the presence of excess (30mg) IP antibody
(IgG, or anti-HuR). RNA in IP materials was used in
RT followed by PCR and qPCR analysis to detect the
presence of occludin and GAPDH mRNAs.
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Flux assays were performed on the 12-mm Transwell as
described in previously (51).
14C-mannitol (MW: 184), a
membrane-impermeable molecule, served as the paracellu-
lar tracer and was added to a ﬁnal concentration of 3.6nM
to the apical bathing wells that contained 0.5ml of
medium. The basal bathing well had no added tracers
and contained 1.5ml of the same ﬂux assay medium as
in the apical compartment. All ﬂux assays were performed
at 37 C, and the basal medium was collected 2h after
addition of
14C-mannitol for a Beckman liquid scintilla-
tion counter. The results were expressed as percentage of
total count values of each tracer.
Surgical procedures
Cecal ligation and puncture (CLP) was induced as desc-
ribed previously (52). Mice were anesthetized by
Nembutal (5.5mg/100-g wt, i.p.), and a midline abdomin-
al incision was performed. The distal portion of the cecum
(1cm) was ligated with 5-0 silk suture. The ligated cecum
was then punctured with a 25-gauge needle and slightly
compressed with an applicator until a small amount of
stool appeared. In sham-operated animals, the cecum
was manipulated but without ligation and puncture, and
was placed back in the peritoneum. The incision was
closed using a 2-layer procedure: 5-0 silk suture on the
muscle layer and the skin, respectively. Mice received
1ml of saline i.p. for ﬂuid resuscitation at the time of
closure and 0.1mg/100-g wt buprenex s.c. 4 times at
12-h intervals to minimize distress.
Intestinal permeability in vivo
Intestinal permeability was determined by examining the
appearance in blood of FITC-dextran administered
by gavage as described (53). Brieﬂy, mice were gavaged
with FITC-dextran at a dose of 60mg/100-g wt 4h before
harvest. Blood sample was collected by cardiac puncture.
The serum concentration of the FITC-dextran was deter-
mined using a ﬂuorescence plate reader with an excitation
wavelength at 490nm and an emission wavelength of
530nm.
Statistics
Values are means±SEM (standard error of the mean)
from 3 to 6 samples. Immunoblotting results were repeated
three times. The signiﬁcance of the difference between
means was determined by analysis of variance. The level
of signiﬁcance was determined using Duncan’s multiple
range test (54).
RESULTS
Occludin mRNA is a direct target of HuR
There are several computationally predicted hits of the
HuR motif in the occludin 30-UTR (55) (Figure 1A), sug-
gesting the involvement of HuR in the post-transcriptional
regulation of occludin. To test this possibility, we ﬁrst ex-
amined whether HuR directly interacts with the occludin
mRNA by performing RNP–IP assays using anti-HuR
antibody under conditions that preserved RNP integrity
(50). As shown in Figure 1B and C, the occludin PCR
products were highly enriched in HuR samples compared
with control IgG samples. The enrichment of c-Myc PCR
product was also examined and served as a positive con-
trol, since c-Myc mRNA is a target of HuR (22), while the
ampliﬁcation of GAPDH PCR products, found in all sam-
ples as low-level contaminating housekeeping transcripts
(not HuR targets), served to monitor the evenness of
sample input, as reported previously (27,48). In addition,
HuR was also found to interact with mRNAs encoding
other intercellular junction proteins such as ZO-1,
claudin-1, E-cadherin and b-catenin, but it did not bind
to mRNAs encoding ZO-2 and JAM-1 (Supplementary
Figure S1). (HuR/occludin mRNA) associations were fur-
ther tested by using biotinylated transcripts which
spanned occludin CR and 30-UTR. Following incubation
with cytoplasmic lysates, the interaction between the
biotinylated occludin transcripts and HuR was examined
by biotin pulldown followed by western blot analysis (23).
The occludin 30-UTR transcripts readily associated with
HuR (Figure 1D), but HuR did not interact with the
occludin CR. The RBP TIAR also formed complexes
with the occludin 30-UTR but not with its CR. Neither
the occludin 30-UTR nor its CR interacted with b-actin,
included here as a negative control.
To deﬁne the speciﬁc HuR-binding regions in the
occludin 30-UTR, various partial biotinylated tran-
scripts spanning the occludin 30-UTR (spanning positions
1721–4141) were prepared as shown (Figure 1E, schemat-
ic). HuR was found to bind predominantly fragment F3
(spanning positions 2791–3425). In contrast, there was no
detectable binding of HuR to fragments F2 and F4 and
only marginal binding to fragment F1. To further narrow
down the HuR-binding sites in the F3 of the occludin
30-UTR, different sub-fragments (S) of F3 were prepared
(Figure 1F, schematic). HuR only formed complexes with
sub-fragment S4 (spanning 3247–3390) of the occludin
30-UTR, the transcript which contained two hits of the
HuR signature motif. These results indicate that HuR
interacts with the occludin mRNA via speciﬁc RNA
segments within its 30-UTR.
HuR interaction with occludin mRNA enhances occludin
translation via its 30-UTR
To examine the functional consequences of HuR inter-
actions with occludin mRNA, we silenced HuR expression
by transfection with siRNA targeting the HuR mRNA
(siHuR). These speciﬁc siHuR nucleotides were designed
to reduce HuR mRNA and to have a unique combination
of speciﬁcity, efﬁcacy and low toxicity (22,42). The levels
of HuR protein were decreased by  85% in cells trans-
fected with siHuR for 48 or 72h (Figure 2A); this reduc-
tion was speciﬁc, as the levels of other RBPs such as TIAR
were not affected in HuR-silenced populations (Figure 2A).
Importantly, HuR silencing reduced occludin protein
(Figure 2A, middle) but it failed to alter the levels of
total occludin mRNA (Figure 2B).
To ascertain if the reduction in occludin expression in
HuR-silenced populations was due to repression of
Nucleic Acids Research, 2011,Vol.39, No. 19 8475occludin translation, we examined the changes in the rate
of new occludin synthesis after HuR silencing. Cells were
incubated in the presence of L-[
35S]methionine and L-
[
35S]cysteine for 30min, whereupon newly translated
occludin was visualized by IP. As shown in Figure 2C,
newly synthesized occludin was markedly lower in
HuR-silenced cells as compared with what was observed
in cells transfected with C-siRNA. HuR silencing did not
appear to affect global protein translation because it did
not inﬂuence nascent GAPDH synthesis. To further deﬁne
the role of HuR in the regulation of occludin mRNA
translation, we examined the relative distributions of
occludin mRNA on individual fractions from polyribo-
some gradients after HuR silencing as described previ-
ously (19,48). In this study, mRNAs in fractions 1–4
were not considered to be translated, because they were
not associated with components of the translation machin-
ery or cosedimented with ribosome subunits (mono-
somes); and transcripts in fractions 5–7 were bound to
single ribosomes or formed polysomes of low molecular
weight and they were considered to be translated at
low-to-moderate levels. Fractions 8–10 comprised the
mRNAs that were associated with polysomes of high mo-
lecular weight and they were thus considered to be actively
translated. Although there were no signiﬁcant changes in
global polysomal proﬁles after HuR silencing (Figure 2D),
the abundance of occludin mRNA in fractions 8 and 9 of
the polysomal proﬁles decreased in HuR-silenced popula-
tions (Figure 2E, left). This redistribution of occludin
mRNA in polyribosomes after HuR silencing was
speciﬁc, as the housekeeping GAPDH mRNA distributed
similarly in the two groups (Figure 2E, right).
Figure 1. HuR binds the occludin mRNA. (A) Schematic representative of the occludin mRNA and the predicted hits of the HuR signature motif in
its 30-UTR. (B) Association of endogenous HuR with endogenous occludin mRNA. After IP of RNA-protein complexes from cell lysates using either
anti-HuR antibody (Ab) or control IgG1, RNA was isolated and used in RT reactions. RT–PCR products of occludin and c-Myc were visualized in
ethidium bromide-stained agarose gels; low-level ampliﬁcation of GAPDH (housekeeping mRNA, which is not HuR targets) served as negative
controls. (C) Fold differences in occludin transcript abundance in HuR IP compared with IgG IP in cells described in panel (B), as measured by RT–
qPCR analysis. Values were means±SEM from triplicate samples. (D) Representative HuR and TIAR immunoblots using the pull-down materials
by biotinylated transcripts of the occludin CR or 30-UTR. Cytoplasmic lysates were incubated with 6mg of biotinylated occludin CR or 30-UTR, and
the resulting RNP complexes were pulled down by using streptavidin-coated beads. The presence of HuR or TIAR in the pull-down material was
assayed by western blotting. b-actin in the pull-down material was also examined and served as a negative control. (E) HuR-binding to different
fractions of 30-UTR of the occludin mRNA. Top panel, schematic representation of the occludin 30-UTR biothinylated transcripts. After incubation
of cytoplasmic lysates with the full-length (FL) or various fractions (F) of the occludin 30-UTR, the resulting RNP complexes were pulled down, and
the abundance of HuR and b-actin proteins in the pull-down material was examined. (F) Mapping the HuR-binding sites in F3 of the occludin
30-UTR. Top panel, schematic representation of the biotinylated transcripts of F3 used in this study.
8476 Nucleic Acids Research, 2011,Vol.39, No. 19To examine whether the translational effect of HuR was
exerted through speciﬁc occludin sequences, the ﬁreﬂy
luciferase reporter gene construct pLuc-Occl-30-UTR
(Figure 2F, left) was generated. To distinguish translation-
al output from changes in mRNA levels, luciferase activity
was normalized to luciferase-reporter mRNA levels to
assess the translation efﬁciency (29,37). HuR silencing
decreased occludin 30-UTR-luciferase reporter gene
activity (Figure 2F, right), indicating that HuR regulates
occludin mRNA translation through the occludin 30-UTR
ARE. In contrast, no changes in luciferase activity were
seen in response to HuR silencing when testing a negative
Figure 2. Changes in occludin translation after HuR silencing. (A) Representative immunoblots of HuR and occludin proteins. After cells were
transfected with either siRNA targeting the HuR mRNA coding region (siHuR) or control siRNA (C-siRNA) for 48 or 72h, whole-cell lysates were
harvested for western blot analysis. (B) Levels of occludin mRNA in cells treated as described in panel (A). Total RNA was harvested, and the levels
of occludin mRNA were measured by RT–qPCR analysis. Data were normalized to GAPDH mRNA levels, and values are means±SEM of data
from triplicate experiments. (C) Newly translated occludin protein. Occludin translation was measured by incubating cells with L-[
35S]methionine
and L-[
35S]cysteine for 30min, followed by immunoprecipitation using an anti-occludin antibody, resolving the immunoprecipitated samples by
SDS–PAGE, transferring the samples, and visualization of signals by using a PhosphorImager. (D) Polysomal proﬁles from cells 48h after trans-
fection with C-siRNA (a) or siHuR (b). Nuclei were pelleted, and the resulting supernatants were fractionated through a 10–50% linear sucrose
gradient. (E) Distributions of occludin (left) and GAPDH (right) mRNAs in each gradient fraction prepared from cells described in panel (D). Total
RNA was isolated from the different fractions, and the levels of occludin and GAPDH mRNAs were measured by RT–qPCR analysis and plotted as
a percentage of the total occludin or GAPDH mRNA levels in that sample. NB, not bound to polysomes; NT, not translated; LMW,
low-molecular-weight polysomes; HMW, high-molecular-weight polysomes. Three independent experiments were performed and showed similar
results. (F) Changes in occludin translation efﬁciency as measured by occludin 30-UTR-luciferase reporter assays. Left, schematic of plasmids: (a),
control (pGL3-Luc); (b), chimeric ﬁreﬂy luciferase-occludin 30-UTR (Luc-Occl-30-UTR). Right, levels of occludin translation. The Luc-Occl-30-UTR
or pGL3-Luc (negative control) was cotransfected with a Renilla luciferase reporter. Luciferase values were normalized to the mRNA levels to obtain
translation efﬁciencies and expressed as means±SEM of data from three separate experiments. *P<0.05 compared with cells transfected with
C-siRNA. (G) Changes in paracellular permeability as measured by using the membrane-impermeable trace molecule
14C-mannitol. Values are
means±SEM of data from six samples. *P<0.05 compared with cells transfected with C-siRNA.
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30-UTR ARE (Figure 2F, left). Importantly, decreased
levels of occludin by HuR silencing also disrupted the in-
testinal epithelial barrier function as indicated by an
increase in the levels of paracellular ﬂux of
14C-mannitol
(Figure 2G). These results indicate that HuR silencing
represses occludin translation via its 30-UTR, thus
leading to epithelial barrier dysfunction in vitro.
The results presented in Figure 3 further showed that
ectopic HuR overexpression increased occludin translation
and enhanced the epithelial barrier function. A vector ex-
pressing wild-type HuR-TAP fusion protein (HuR-TAP)
was generated as described (42). Overexpression of
HuR-TAP increased the levels of exogenous HuR-TAP
proteins and occludin without affecting the levels of en-
dogenous HuR (Figure 3A, middle). Increased HuR
induced occludin by enhancing its translation, because
HuR overexpression increased the occludin 30-UTR-
luciferase reporter gene activity (Figure 3B) but did not
induce the levels of total occludin mRNA (Figure 3C). In
contrast, neither HuR protein levels nor occludin expres-
sion were altered by transfection with the control vector.
Consistent with these observations, increased levels of
occludin by HuR overexpression also enhanced the epi-
thelial barrier function as shown by a decrease in the levels
of paracellular ﬂux of
14C-mannitol (Figure 3D). These
results indicate that increasing HuR levels stimu-
lates occludin translation and improves epithelial barrier
function.
Chk2-dependent HuR phosphorylation modulates
HuR-binding to occludin mRNA
Recently, Chk2 was shown to physically interact with and
modulate HuR function by regulating its phosphorylation
(22,42). To determine the implication of Chk2-dependent
HuR phosphorylation in the control of occludin mRNA
translation, we examined changes in the levels of phos-
phorylated HuR (p-HuR) and its binding afﬁnity for
occludin mRNA after Chk2 silencing. Inhibition of Chk2
by transfection with speciﬁc siRNA targeting the coding
region of Chk2 mRNA (siChk2) decreased p-HuR levels
(Figure 4A), although it did not alter whole-cell HuR
content. The inhibition of HuR phosphorylation by
Chk2 silencing not only reduced (HuR/occludin mRNA)
association (Figure 4B and C) but also repressed occludin
mRNA translation, as indicated by a decrease in levels of
occludin ARE luciferase reporter gene activity [Figure 4D
(a)]. In contrast, Chk2 silencing failed to alter the levels of
total occludin mRNA [Figure 4D (b)]. Consistently,
occludin protein levels declined in Chk2-silenced popula-
tions (Figure 4E); the epithelial barrier function was also
disrupted, as indicated by an increase in the levels of para-
cellular ﬂux of
14C-mannitol (Figure 4F). These results
indicate that Chk2 was essential for HuR-binding to the
occludin mRNA and played an important role in the regu-
lation of occludin mRNA translation.
Based on the analysis of the occludin 30-UTR (Figure 1E
and F), HuR predominantly binds occludin transcript F3.
To determine if Chk2-dependent HuR phosphorylation
regulates occludin translation by interacting speciﬁcally
with this fragment, we generated reporter constructs that
expressed chimeric RNA containing the luciferase and par-
tial transcripts spanning the occludin 30-UTR, as shown in
Figure 5A and B (top panels). The results presented in
Figure 5A show that decreased HuR/occludin mRNA
interaction by Chk2 silencing repressed translation efﬁ-
ciency, as indicated by a decrease in the levels of reporter
gene activity when cells were transfected with pLF3 (con-
taining the HuR-binding site). In contrast, basal levels of
reporter gene activity of the constructs pLF1, pLF2 or
pLF4 (without HuR-binding sites) were very low and
they were also unaffected by Chk2 silencing. Analysis of
Figure 3. Changes in occludin translation after ectopic HuR
overexpression. (A) Representative immunoblots of HuR-TAP fusion
protein (HuR-TAP), endogenous HuR and occludin proteins. Cells
were transfected with the vector expressing wild-type HuR-TAP or
control emptying vector; protein levels were measured by western im-
munoblotting analysis 48h after the transfection using speciﬁc antibody
against TAP, HuR or occludin. (B) Changes in occludin translation
efﬁciency as measured by using pGL3-Luc-Occl-30-UTR reporter
assays in cells described in panel (A). Twenty-four hours after cells
were transfected with the Luc-Occl-30-UTR or pGL3-Luc, the levels
of luciferase activity were examined and normalized to the mRNA
levels to obtain translation efﬁciencies. Values were expressed as
means±SEM of data from three separate experiments. *P<0.05
compared with controls and cells transfected with emptying vector.
(C) Levels of occludin mRNA as measured by RT–qPCR analysis in
cells described in panel (A). The data were normalized to GAPDH
mRNA levels, and shown as the means±SEM of data from triplicate
experiments. (D) Changes in paracellular permeability as measured by
the membrane-impermeable trace molecule
14C-mannitol ﬂux assays.
Values are means±SEM of data from six samples. *P<0.05
compared with controls and cells transfected with the emptying
vector alone.
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of F3 revealed that Chk2 silencing decreased the levels
of reporter gene activity when cells were transfected with
pLS4 (containing HuR-binding site) but it failed to reduce
the reporter activity of pLS1, pLS2, pLS3 and pLS5 in
which HuR-binding sites were deleted (Figure 5B). To
further deﬁne the role of the S4 region in regulating
occludin mRNA translation, we generated a reporter con-
struct in which the S4 was deleted from the occludin
30-UTR (pL-FL-MS4; Figure 5C schematic). Deletion of
S4 from the occludin 30-UTR abrogated the Chk2- and
HuR-dependent regulation, since silencing HuR or Chk2
failed to alter the translation efﬁciency of reporter
pL-FL-MS4. Consistent with this observation, deletion
mutation of the S4 fragment from the occludin 30-UTR
also disrupted HuR association with the occludin 30-UTR
as measured by RNP/IP–qPCR analysis (Figure 5D).
These data strongly suggest that the HuR-binding region
located at the F3-S4 fragment is primarily responsible for
the regulatory processes mediated by HuR.
Given the fact that Chk2 phosphorylates HuR at
residues S88, S100 and T118 and that each individual
phosphorylation site by Chk2 plays a distinct role in regu-
lating HuR- binding to different target mRNAs (22,42),
we further tested HuR mutants with alanine substitutions
at each of the Chk2 phosphorylation sites. As shown in
Figure 4. Chk2-dependent HuR phosphorylation regulates HuR-binding to occludin mRNA and alters its translation. (A) Representative
immunoblots of Chk2, total HuR (T-HuR) and phosphorylated HuR (p-HuR) after Chk2 silencing. Cells were transfected with either siRNA
targeting the Chk2 mRNA coding region (siChk2) or control siRNA (C-siRNA) for 48h, and whole-cell lysates were harvested for western blot
analysis to examine the levels of Chk2 and HuR, and loading control b-actin. To assess the levels of p-HuR, cell lysates were subjected to IP using an
anti-HuR antibody, and the precipitates were analyzed by western blotting with the antibody against phosphorylated proteins (pProteins) or
anti-HuR antibody. (B) Changes in HuR-binding to occludin mRNA as detected by biotin pull down assays: (a) binding to 30-UTR; and (b)
binding to coding region (CR). (C) Association of endogenous HuR with endogenous occludin mRNA in cells described in (A). Whole-cell lysates
were used for IP in the presence of anti-HuR antibody or nonspeciﬁc IgG; and the levels of occludin and GAPDH mRNAs in the IP material were
examined by RT–qPCR analysis. Values are the means±SEM of data from three samples. *P<0.05 compared with cells transfected with the
C-siRNA. (D) Changes in occludin translation efﬁciency (a) and occludin mRNA levels (b) as measured by using Luc-Occl-30-UTR reporter assays
and RT–qPCR analysis in cells described in (A). Data were expressed as means±SEM of data from three separate experiments. *P<0.05 compared
with cells transfected with Con-siRNA. (E) Levels of occludin protein in Chk2-silenced cells. Data are representative from three independent
experiments showing similar results. (F) Changes in paracellular permeability. Values are means±SEM of data from six samples. *P<0.05
compared with controls and cells transfected with C-siRNA.
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sites modulated HuR-binding to the occludin mRNA and
altered occludin expression. Point mutations at each indi-
vidual Chk2 phosphorylation site in HuR affected its
binding to the occludin mRNA differently (Figure 6B,
top), but they did not affect the levels of total occludin
mRNA (Figure 6B, bottom). The S100A mutation decre-
ased HuR association with the occludin mRNA
and reduced occludin protein level when compared with
those obtained from cells expressing HuR(WT)-TAP.
In contrast, S88A and T118A mutations did not affect
their binding to the occludin mRNA, as the levels of
the binding complexes and occludin protein in cells
expressing HuR(S88A)-TAP or HuR(T118A)-TAP were
similar to those observed in cells expressing HuR(WT)-
TAP. We also examined the effect of coexpressing Chk2
and different HuR-TAP mutants on HuR association
with the occludin mRNA and found that point mutation
at Chk2 phosphorylation sites in HuR also altered
Chk2-induced HuR-binding to the occludin mRNA, in
turn affecting occludin translation. The results presented
in Figure 6C show that Chk2 overexpression alone slightly
increased occludin protein expression level compared
with those observed in cells transfected with the control
vector, but coexpression of Chk2 with HuR(WT)-TAP,
HuR(S88A)-TAP or HuR(T118A)-TAP remarkably
increased the levels of occludin protein. On the other
hand, coexpression of Chk2 and HuR(S100A)-TAP
did not increase occludin translation, because the levels
of occludin protein were similar in the Chk2 alone
and Chk2+HuR(S100A) groups. When the association
of HuR with the occludin mRNA was examined, the
Figure 5. Impact of deleting the HuR-interacting RNA from the occludin 30-UTR on HuR-mediated occludin translation. (A and B) Changes in the
levels of occludin 30-UTR luciferase reporter activity in Chk2-silenced cells. Top panels: schematic of ﬁreﬂy luciferase (FL) reporter constructs
containing different fragments of the occludin 30-UTR. Twenty-four h after the cells were transfected with either siRNA targeting the Chk2 mRNA
coding region (siChk2) or control siRNA (C-siRNA), the cells were further transfected with each of various occludin 30-UTR luciferase reporter
constructs and a Renilla luciferase control reporter. The levels of ﬁreﬂy and Renilla luciferase activities were assayed 24h later. The results were
normalized to the Renilla luciferase activity and are shown as the means±SEM of data from three separate experiments. *P<0.05 compared with
cells transfected with C-siRNA. (C) Activity of luciferase reporters containing the occludin 30-UTR with the S4 mutation after silencing HuR or
Chk2. Cells were initially transfected with either siHuR, siChk2 or C-siRNA and 24h later they were further transfected with pL-FL or pL-FL-MS4
together with the Renilla luciferase reporter. *P<0.05 compared with cells transfected with C-siRNA. (D) Changes in HuR association with the
occludin 30-UTR after deleting the S4 sequence. Twenty-four hours after cells were transfected with pL-FL or pL-FL-MS4, whole-cell lysates were
used for IP in the presence of anti-HuR antibody (left) or non-speciﬁc IgG1 (right). RNA in the IP material was used in RT–PCR reactions to detect
the presence of occludin 30-UTR (S3–S5), and the resulting PCR product (402bp) were visualized in agarose gels. Three separate experiments were
performed that showed similar results.
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transfected with the Chk2 alone but was remarkably
elevated in cells coexpressing Chk2 and HuR(WT)-TAP,
HuR(S88A)-TAP or HuR(T118A)-TAP, but not
HuR(S100A)-TAP (Figure 6D, top). In addition,
coexpression of Chk2 with either HuR(WT)-TAP or dif-
ferent HuR-TAP mutants failed to alter total occludin
mRNA levels (Figure 6D, bottom). Taken together, these
ﬁndings indicate that phosphorylation at residue S100 by
Chk2 enhances HuR-binding to the occludin mRNA,
Figure 6. Ectopic overexpression of HuR carrying point mutations modulates occludin expression by altering (HuR/occludin mRNA) association.
(A) Representative immunoblots of HuR-TAP fusion proteins (HuR-TAP), endogenous HuR, and occludin proteins. Cells were transfected with the
vector expressing wild-type (WT) HuR-TAP or mutated HuR-TAP fusion proteins, and the protein levels were measured by western immunoblotting
analysis 48h after the transfection using speciﬁc antibody against TAP, HuR or occludin. (B) Changes in levels of the occludin mRNA in TAP IP
materials (top) and total occludin mRNA (bottom) in cells described in panel (A). Total occludin mRNA levels were measured by RT–qPCR
analysis, while binding of chimeric HuR-TAP proteins to occludin mRNA was examined by performing TAP IP followed by RT–qPCR analysis.
Values are means±SEM of data from three separate experiments. *
,+ P<0.05 compared with controls (vector) and cells transfected with the
HuR(WT)-TAP, respectively. (C) Changes in levels of occludin protein after overexpression of Chk2 and chimeric HuR-TAP proteins. Cells were
cotransfected with the Chk2 expression vector (Chk2) and vectors expressing HuR (WT)-TAP or mutated HuR-TAP fusion proteins. The levels of
Chk2, HuR-TAP, endogenous HuR and occludin proteins were measured 48h after the transfection. (D) Changes in levels of the occludin mRNA in
TAP IP materials (top) and total occludin mRNA (bottom) in cells described in panel (C) as measured by RT–qPCR analysis. *P<0.05 compared
with cells transfected with the emptying vector;
+P<0.05 compared with cells cotransfected with Chk2 and HuR(WT)-TAP.
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action; these modiﬁcations in turn regulate occludin
translation.
Inhibition of Chk2 by polyamine depletion reduces
(HuR/occludin mRNA) complexes and represses
occludin translation
Polyamines (spermidine, spermine and their precursor
putrescine) are ubiquitous polycationic molecules in eu-
karyotic cells and are implicated in many aspects of bio-
logical functions including the control of the gut barrier
(40,55). In this study, we examined if polyamines regulate
occludin translation by altering Chk2-dependent HuR
phosphorylation. Consistent with our previous studies
(56,57), inhibition of ODC (a key enzyme for polyamine
biosynthesis) by treatment with DFMO for 4 days com-
pletely depleted the cellular polyamines putrescine and
spermidine and signiﬁcantly decreased spermine level
(Supplementary Figure S2). As shown in Figure 7A,
polyamine depletion by DFMO inhibited Chk2 expression
and decreased the levels of p-HuR, although it did not
change whole-cell HuR levels. Polyamine depletion also
inhibited HuR association with the occludin mRNA
(Figure 7B and C); this reduction was mediated through
occludin 30-UTR. The decreased levels of (HuR/occludin
mRNA) complexes in polyamine-deﬁcient cells were accom-
panied by reductions of occludin translation (Figure 7D)
and occludin protein abundance (Figure 7E). Furthermore,
the reduced occludin levels in cells with decreased p-HuR
through polyamine depletion were also associated with the
epithelial barrier dysfunction as indicated by an increase
in levels of paracellular ﬂux of [
14C]mannitol (Figure 7F).
In the presence of DFMO, exogenous putrescine not only
prevented reduced levels of Chk2 and (HuR/occludin
mRNA) complexes but also returned occludin translation
to near-normal levels. Consistently, the epithelial barrier
function also returned to normal when putrescine was
Figure 7. Polyamine depletion represses occludin translation by decreasing Chk2-dependent HuR phosphorylation. (A) Representative immunoblots
of Chk2, total HuR (T-HuR), and phosphorylated HuR (p-HuR) in polyamine-deﬁcient cells. After cells were grown in control media and in media
containing DFMO (5mM) or DFMO plus putrescine (Put; 10mM) for 4 days, whole cell lysates were harvested. The levels of Chk2, T-HuR and
p-HuR were measured by western blot analysis, while the levels of p-HuR were examined by immunoprecipitation (IP) assays. (B) Changes in
HuR-binding to occludin mRNA as detected by biotin pull down assays in cells described in panel (A): (a) binding to 30-UTR; and (b) binding to
coding region (CR). (C) Association of endogenous HuR with endogenous occludin mRNA as measured by RNP–IP/RT–qPCR assays. Values are
means±SEM of data from six samples. *P<0.05 compared with controls and cells treated with DFMO plus Put. (D) Changes in occludin
translation efﬁciency as measured by Luc-Occl-30-UTR reporter assays in cells described in (A). Data were expressed as means±SEM of data
from three samples. *P<0.05 compared with controls and cells exposed to DFMO plus Put. (E) Representative immunoblots of occludin protein. (F)
Changes in paracellular permeability in cells described in panel (A). Values are means±SEM of data from six samples. *P<0.05 compared with
controls and cells exposed to DFMO plus Put.
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signiﬁcant differences in the levels of total occludin mRNA
between control cells and cells exposed to DFMO alone or
DFMO plus putrescine (Supplementary Figure S3). These
results indicate that polyamine depletion represses oc-
cludin translation by decreasing (HuR/occludin mRNA)
association as a result of a reduction in Chk2-dependent
HuR phosphorylation.
Septic stress decreases Chk2 and reduces HuR/occludin
mRNA association in vivo
To assess the physiologic role of Chk2/HuR in the regu-
lation of occludin expression in vivo and their involvement
in pathogenesis of the gut barrier dysfunction after surgical
stress, we investigated if intestinal Chk2 expression and
HuR/occludin mRNA interactions were changed in
sepsis using the cecal ligation and puncture (CLP) model
(52). As shown in Figure 8A, mucosal Chk2 and occludin
expression levels in the small intestine decreased markedly
after sublethal CLP, although there were no changes in
total HuR levels in CLP-mice. The maximal decrease in
the levels of Chk2 and occludin proteins occurred between
24 and 48h after CLP, whereas expression of Chk2 and
occludin began to gradually recover at 72h and almost
returned to normal level at 120h after CLP. To examine
changes in cellular distribution of Chk2 and microscopic
injury of the small intestine after CLP, we found that
Chk2 immunostaining was predominantly located at the
villous area of the mucosa and its intensity decreased dra-
matically after CLP (Figure 8B). Focal villous necrosis in
the intestine was observed at 24 and 48h after CLP; the
damage was repaired within the next 48h. Sham operation
did not affect expression of Chk2, occludin levels or gut
epithelial integrity. On the other hand, CLP stress also
resulted in gut barrier dysfunction as indicated by an in-
crease in intestinal mucosal permeability to FITC-dextran
Figure 8. Reduction in Chk2 associates with inhibition of the occludin expression and gut barrier dysfunction in mice exposed to CLP. (A)
Representative immunoblots of Chk2, occludin and HuR proteins in the small intestinal mucosa after CLP. The mucosal tissues were harvested
at different times as indicated after CLP surgery; and changes in the levels of Chk2, occludin and HuR proteins were measured by western
immunoblotting analysis. The results in each panel were from separate experiments. (B) Immunohistochemical staining of Chk2 in the small intestinal
mucosa in control (a) and mice exposed to CLP for 24h (b). c, crypt; v, villous; arrow, Chk2 immunostaining. (C) Changes in gut permeability as
measured by FITC-dextran tracer ﬂux assays in animals described in panel (A). FITC-dextran was given orally, and blood samples were collected 4h
thereafter for measurement. Values are means±SEM of data from ﬁve samples. *
,+P<0.05 compared with controls (0h) and animals exposed to
CLP for 24h, respectively. (D) Association of HuR with occludin mRNA in the small intestinal mucosa as measured by RNP–IP/RT–qPCR analysis.
Values are means±SEM of data from ﬁve samples. *
,+P<0.05 compared with controls (0h) and animals exposed to CLP for 24h, respectively. (E)
The levels of total occludin mRNA in the intestinal mucosa as measured by RT–qPCR analysis in mice exposed to CLP. Values are means±SEM of
data from ﬁve samples.
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ability occurred at 24 and 48h after the stress. Consistent
with the recovery of Chk2 and occludin expression, gut
barrier function partially recovered at 72 and 96h after
CLP and restored to near-normal level at 120h thereafter.
To determine the mechanism underlying the repression of
occludin expression induced by CLP, we examined the
changes in levels of total occludin mRNA and its inter-
action with HuR. Exposure to CLP stress decreased the
association of occludin mRNA with HuR as measured by
RNP–IP/qPCR analysis (Figure 8D), but it failed to affect
total occludin mRNA levels (Figure 8E). The maximal re-
duction in the levels of (HuR/occludin mRNA) complexes
occurred at 24 and 48h after CLP and recovered gradually
thereafter. The levels of (HuR/occludin mRNA)
complexes at 120h after CLP were similar to those
observed in control interventions. These ﬁndings suggest
that CLP-induced repression of occludin expression
occurs at the post-transcriptional level and that decreased
HuR association with the occludin mRNA following
Chk2 reduction plays a role in pathogenesis of the gut
barrier dysfunction in response to CLP stress.
Polyamine depletion represses occludin expression and
delays gut barrier recovery
Given the fact that decreasing cellular polyamines by
DFMO inhibited Chk2 and dissociated (HuR/occludin
mRNA) complexes in cultured IECs (Figure 7), we ex-
amined the effect of Chk2 inhibition by polyamine deple-
tion on HuR/occludin mRNA interaction in the intestinal
mucosa after CLP. In this study, half of the mice were
given DFMO, 50mg/100-g body weight, i.p. immediately
after CLP, and then 2% DFMO was given in the drinking
water throughout the entire period of experiment. Our
previous studies show that this dose of DFMO completely
prevents increases in ODC and decreases tissue polyamine
content after the stress (58,59). As shown in Figure 9A and
B, the DFMO-decreased levels of cellular polyamines did
not additionally reduce the levels of (HuR/occludin
mRNA) complexes and occludin protein at 24h after
CLP. The normal recovery of HuR-binding to the occludin
mRNA and occludin expression that occurred by 72 and
96h after CLP, however, was prevented by polyamine de-
pletion. In the animals treated with DFMO, there was no
signiﬁcant increase in the levels of (HuR/occludin mRNA)
complexes and occludin protein at 72 and 96h after CLP.
In contrast, DFMO treatment did not affect total occludin
mRNA levels in CLP-mice. Consistently, polyamine de-
pletion also delayed recovery of the gut barrier function at
72 and 96h after CLP, although it failed to additionally
increase gut permeability at 24h in CLP-mice (Figure 9C).
These results suggest that recovery of HuR/occludin
mRNA association via Chk2 and the ensuing occludin
upregulation are involved in the reestablishment of gut
barrier function after septic stress.
DISCUSSION
Although the importance of occludin in the assembly and
regulation of TJs is well documented (1–3,9–11,14), little is
known about the post-transcriptional control of occludin
expression. In the present study, we uncover a novel
function of the RBP HuR in the regulation of occludin
mRNA translation and therefore in the intestinal barrier
Figure 9. Polyamine depletion reduces (HuR/occludin mRNA) associ-
ation and delays the recovery of occludin expression and gut barrier
function in CLP-mice. (A) Changes in the levels of occludin mRNA in
HuR IP materials (top) and total occludin mRNA (bottom). After CLP
surgery, mice were injected i.p. with saline or DFMO at the dose of
5mg/10-g body wt, followed by 2% DFMO in their drinking water
throughout the experiment. Binding of HuR to occludin mRNA was
examined by RNP-IP/RT–qPCR analysis, while total occludin mRNA
levels were measured by RT–qPCR analysis. Values are means±SEM
of data from ﬁve samples. *P<0.05 compared with CLP-mice treated
with saline. (B) Representative immunoblots of occludin protein in the
small intestinal mucosa from mice described in panel (A). (C) Changes
in gut permeability as measured by FITC-dextran tracer ﬂux assays.
Values are means±SEM of data from ﬁve samples. *P<0.05
compared with CLP-mice treated with saline.
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by directly interacting with its 30-UTR and promoted
occludin translation in vitro as well as in vivo.
Experiments aimed at characterizing the molecular aspects
of this process suggested that HuR associates with the
occludin mRNA through Chk2-dependent HuR phos-
phorylation, likely at residue S100. Reduced HuR phos-
phorylation by Chk2 silencing or inhibition of Chk2
activity via polyamine depletion decreased the afﬁnity of
HuR for the occludin mRNA and repressed occludin
translation, whereas Chk2 overexpression enhanced
HuR association with the occludin mRNA and stimulated
its expression. Our results also suggest that Chk2-
dependent HuR phosphorylation is a critical factor for
maintenance of the gut barrier integrity during septic
stress in mice.
The results reported herein provide a comprehensive
view of HuR interaction with the occludin mRNA and
its regulation. HuR associated with the occludin 30-UTR
at a segment spanning position 3164–3306, which contains
two predicted hits of the HuR signature motif (Figure 1),
but it did not interact with the occludin CR. We did not
identify the speciﬁc occludin 30-UTR nucleotides with
which HuR interacts, since those experiments would re-
quire more specialized biochemical, crystallographic and
molecular methods than those used here. Our results
further indicate that HuR association with the occludin
mRNA enhances occludin translation without affecting
total occludin mRNA levels. The occludin mRNA trans-
lation was decreased in HuR-silenced cells, but it was
increased in cells overexpressing HuR. These ﬁndings are
consistent with observations from others who demonst-
rated that HuR binds to the speciﬁc signature motifs in
its target mRNAs and plays a general role as an en-
hancer of mRNA translation, as described for tran-
scripts such as p53 (49), c-Myc (22), thrombospondin-1
(60), prothymosin-a (61), cytochrome c (48), MKP-1
(62), HIF-1a (63) and MEK1 (21) mRNAs. In addition,
HuR also stabilizes SIRT1 (42), XIAP (27), VEGF (64),
nucleophosmin (43) and ATF-2 (23) mRNAs, in turn
inducing protein expression levels.
An important ﬁnding from the present study is that
Chk2-dependent HuR phosphorylation is essential for
HuR-binding to the occludin mRNA and thus plays a
role in maintenance of normal epithelial barrier
function. In Chk2-silenced cells, the levels of phosphory-
lated HuR decreased, (HuR/occludin mRNA) complexes
dissociated and occludin mRNA translation declined,
leading to barrier dysfunction (Figure 4). HuR is ubiqui-
tously expressed and an RNA signature motif recognized
by HuR is widely found in numerous mRNAs (26), sug-
gesting that HuR can bind to a broad range of mRNAs
and can inﬂuence their post-transcriptional fates.
Increasing evidence indicates that the ability of HuR to
bind a given mRNA and the speciﬁcity of HuR function
are tightly regulated by numerous factors including HuR
phosphorylation and binding of other RBPs and
microRNAs (22,29,30,42). HuR was reported to be phos-
phorylated by Chk2 kinase in vivo as well as in vitro and
this post-translational modiﬁcation altered HuR’s associ-
ation with given target transcripts (22,42). HuR
association with the SIRT1 and c-Myc mRNAs depends
upon its phosphorylation by Chk2 (22,42), but
HuR-binding to the mRNAs encoding p53,
nucleophosmin, ATF-2 and XIAP appears to be inde-
pendent of HuR phosphorylation (23,27,43). HuR is
also shown to recruit the microRNA let-7/RISC
complex to c-Myc 30-UTR and repress c-Myc translation
in HeLa cells (30), whereas it enhances c-Myc translation
in intestinal epithelial cells that lack microRNA let-7 (22).
Studies using various HuR mutations revealed that
HuR phosphorylation at residue S100 by Chk2 is crucial
for the modulation of (HuR/occludin mRNA) associ-
ation, although the exact role of HuR phosphorylation
at the putative Chk2 target residues is not yet understood
in full detail. The association of HuR(WT) with occludin
mRNA was disrupted by the S100A mutation, but not by
the S88A or T118A mutations (Figure 6). Consistent with
changes in the pattern of (HuR/occludin mRNA) inter-
actions, cells overexpressing HuR(S100A) showed
decreased occludin protein levels relative to cells express-
ing HuR(WT), HuR(S88A) or HuR(T118A). Our recent
study also shows that compared with HuR(WT),
HuR(S100A) showed reduced binding to the c-Myc
mRNA, while HuR(S88A) showed enhanced binding;
HuR(T118A) showed the same binding as HuR(WT)
(22). These observations, together with our previous
studies (22,42), support the notion that HuR mutants
lacking a given Chk2 phosphorylation site display
distinct binding afﬁnities for different target mRNAs.
Our results also indicate that Chk2-dependent HuR
phosphorylation is regulated by cellular polyamines.
Maintenance of intestinal mucosal epithelial integrity
requires polyamines and their intracellular levels are tightly
controlled under biological conditions (40,56–59,65). The
regulation of cellular polyamines has been recognized for
many years as a central convergence point for the multiple
signaling pathways driving various epithelial cell functions
(65). We recently demonstrated that decreasing cellular
polyamines inhibited occludin expression and also
decreased the levels of phosphorylated HuR (20,22).
Although the mechanisms by which polyamines regulate
occludin expression remain to be elucidated in full, our
current studies show that polyamine depletion by
DFMO decreased (HuR/occludin mRNA) complexes
and repressed occludin mRNA translation (Figure 7).
Exogenous polyamine putrescine when given together
with DFMO prevented Chk2 inhibition and restored
HuR phosphorylation and its binding afﬁnity for the
occludin mRNA, thereby promoting occludin translation
and the epithelial barrier function. Consistent with our
current ﬁndings, polyamines are also shown to increase
HuR-binding to the c-Myc mRNA through enhancement
of Chk2-dependent HuR phosphorylation (22).
Another major ﬁnding of the present study is that
Chk2-dependent HuR phosphorylation is implicated in
the maintenance and re-establishment of the gut barrier
integrity under critical surgical stress. CLP stress
decreased Chk2 levels, reduced (HuR/occludin mRNA)
complexes, and inhibited occludin abundance, thus
contributing to the pathogenesis of gut barrier dysfunc-
tion (Figure 8). In contrast, induced Chk2-dependent
Nucleic Acids Research, 2011,Vol.39, No. 19 8485HuR phosphorylation at later phase after CLP appears to
be crucial for the recovery of occludin expression and the
gut barrier function, because Chk2 inhibition by
polyamine depletion prevented the induction in occludin
expression and delayed the re-establishment of barrier
function at 72 and 96h in septic mice with administration
with DFMO (Figure 9). Although there are potential
concerns about the speciﬁcity of DFMO, Chk2 inhibition,
and the involvement of other TJ proteins or factors in this
process, to our knowledge, these results are the ﬁrst to
show an association between the expression of occludin
via Chk2-dependent HuR phosphorylation and the main-
tenance of gut barrier integrity under pathological condi-
tions. In summary, together our current ﬁndings indicate
that Chk2-dependent HuR phosphorylation regulates
occludin mRNA translation and helps to maintain and
re-establish epithelial barrier function in the intestinal
tract in response to stress.
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